SG10202101500WA - PPARγ AGONIST FOR TREATMENT OF BONE DISORDERS - Google Patents
PPARγ AGONIST FOR TREATMENT OF BONE DISORDERSInfo
- Publication number
- SG10202101500WA SG10202101500WA SG10202101500WA SG10202101500WA SG10202101500WA SG 10202101500W A SG10202101500W A SG 10202101500WA SG 10202101500W A SG10202101500W A SG 10202101500WA SG 10202101500W A SG10202101500W A SG 10202101500WA SG 10202101500W A SG10202101500W A SG 10202101500WA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- bone disorders
- pparγ agonist
- pparγ
- agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376732P | 2016-08-18 | 2016-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202101500WA true SG10202101500WA (en) | 2021-03-30 |
Family
ID=61197122
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901328VA SG11201901328VA (en) | 2016-08-18 | 2017-08-18 | Ppar? agonist for treatment of bone disorders |
| SG10202101500WA SG10202101500WA (en) | 2016-08-18 | 2017-08-18 | PPARγ AGONIST FOR TREATMENT OF BONE DISORDERS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901328VA SG11201901328VA (en) | 2016-08-18 | 2017-08-18 | Ppar? agonist for treatment of bone disorders |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190167660A1 (ko) |
| EP (1) | EP3500269A4 (ko) |
| JP (2) | JP2019524889A (ko) |
| KR (1) | KR20190065252A (ko) |
| CN (1) | CN109843292A (ko) |
| AU (1) | AU2017313842A1 (ko) |
| BR (1) | BR112019003133A2 (ko) |
| CA (1) | CA3033971A1 (ko) |
| EA (1) | EA201990513A1 (ko) |
| SG (2) | SG11201901328VA (ko) |
| WO (1) | WO2018035449A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202103552XA (en) | 2015-03-09 | 2021-05-28 | Intekrin Therapeutics Inc | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
| AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL357678A1 (en) * | 2000-04-28 | 2004-07-26 | Sankyo Company, Limited | Ppargamma modulators |
| US7223761B2 (en) * | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| US20050250820A1 (en) * | 2004-03-08 | 2005-11-10 | Amgen Inc. | Therapeutic modulation of PPARgamma activity |
| US9061020B2 (en) * | 2013-01-30 | 2015-06-23 | Intekrin Therapeutics, Inc. | PPAR gamma agonists for treatment of multiple sclerosis |
| MX2017004733A (es) * | 2014-10-10 | 2017-07-17 | Prometic Pharma Smt Ltd | Compuestos aromaticos sustituidos y composiciones farmaceuticas para la prevencion y tratamiento de osteoporosis. |
-
2017
- 2017-08-18 US US16/326,070 patent/US20190167660A1/en not_active Abandoned
- 2017-08-18 JP JP2019530368A patent/JP2019524889A/ja active Pending
- 2017-08-18 WO PCT/US2017/047584 patent/WO2018035449A1/en unknown
- 2017-08-18 CA CA3033971A patent/CA3033971A1/en active Pending
- 2017-08-18 SG SG11201901328VA patent/SG11201901328VA/en unknown
- 2017-08-18 KR KR1020197007605A patent/KR20190065252A/ko not_active Application Discontinuation
- 2017-08-18 BR BR112019003133-2A patent/BR112019003133A2/pt not_active IP Right Cessation
- 2017-08-18 CN CN201780063392.8A patent/CN109843292A/zh active Pending
- 2017-08-18 SG SG10202101500WA patent/SG10202101500WA/en unknown
- 2017-08-18 EA EA201990513A patent/EA201990513A1/ru unknown
- 2017-08-18 AU AU2017313842A patent/AU2017313842A1/en not_active Abandoned
- 2017-08-18 EP EP17842205.1A patent/EP3500269A4/en not_active Withdrawn
-
2022
- 2022-06-03 JP JP2022090843A patent/JP2022116294A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018035449A1 (en) | 2018-02-22 |
| AU2017313842A1 (en) | 2019-03-07 |
| EA201990513A1 (ru) | 2019-08-30 |
| JP2022116294A (ja) | 2022-08-09 |
| CN109843292A (zh) | 2019-06-04 |
| EP3500269A1 (en) | 2019-06-26 |
| EP3500269A4 (en) | 2020-04-15 |
| CA3033971A1 (en) | 2018-02-22 |
| KR20190065252A (ko) | 2019-06-11 |
| US20190167660A1 (en) | 2019-06-06 |
| SG11201901328VA (en) | 2019-03-28 |
| BR112019003133A2 (pt) | 2019-05-21 |
| JP2019524889A (ja) | 2019-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304429A (en) | Methods and preparations for the treatment of epileptic disorders | |
| ZA201901279B (en) | Compositions and methods for treatment of neurological disorders | |
| HK1257222A1 (zh) | 經巴氏滅菌的艾克曼菌用於治療代謝病症的用途 | |
| IL271085A (en) | Bacteria to treat disorders | |
| IL253945A0 (en) | kdm1a inhibitors to treat the disease | |
| IL257252A (en) | Methods for treating fgf21-related disorders | |
| IL270752B (en) | Pyrrolopyridine-aniline compounds for the treatment of skin disorders | |
| IL259861A (en) | Methods and preparations for the treatment of disorders related to seizures | |
| EP3432892A4 (en) | ANTAGONISTS DERIVED FROM FIMH MANNOSIS USEFUL FOR THE TREATMENT OF A DISEASE | |
| HK1256721A1 (zh) | 用於治療眼部病症的化合物和組合物 | |
| IL258593A (en) | Compounds for the treatment of subculture disorders | |
| IL274223A (en) | Method of treating acid-base disorders | |
| IL269604A (en) | Pentides for the treatment of autoimmune diseases | |
| SG10202101501PA (en) | PPARγ AGONIST FOR TREATMENT OF BLOOD CANCERS | |
| IL270576B (en) | Hetero-aromatic-aniline compounds for the treatment of skin disorders | |
| GB201612043D0 (en) | Composition for treatment of disorders | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| IL257935A (en) | Treatment of bone growth disorders | |
| IL274747A (en) | FXR agonists for the treatment of liver diseases | |
| SG10202101500WA (en) | PPARγ AGONIST FOR TREATMENT OF BONE DISORDERS | |
| IL266243A (en) | Use of senicapoc for the treatment of neuropathic pain | |
| EP3200795A4 (en) | Use of agents for treating fat-related disorders | |
| GB201604359D0 (en) | Treatment of tissue disorders | |
| RS65014B1 (sr) | Bromheksin za lečenje bola | |
| PL3720467T3 (pl) | Sposoby leczenia bólu neuropatycznego |